Objective: To examine the modern epidemiology of abdominal aortic aneurysm (AAA) rupture and short-term AAA-related mortality after the introduction of endovascular aneurysm repair (EVAR). Background: Previous epidemiologic studies have demonstrated stable rates of AAA repair, repair mortality, and AAA rupture. Recently, EVAR has been introduced as a less invasive treatment method, and its use has expanded to more than 75% of elective AAA repairs. Methods: We identified Medicare beneficiaries undergoing AAA repair and those hospitalized with a ruptured AAA during the period 1995 to 2008 and calculated standardized annual rates of AAA-related deaths due to either elective repair or rupture. Results: A total of 338,278 patients underwent intact AAA repair during the study period. There were 69,653 patients with AAA rupture, of whom 47,524 underwent repair. Intact repair rates increased substantially in those older than 80 years (57.7-92.3 per 100,000, P < 0.001) but decreased in those 65 to 74 years old (81.8-68.9, P < 0.001). A decline in ruptures with and without repair was seen in all age groups. By 2008, 77% of all intact repairs and 31% of all rupture repairs were performed with EVAR (P < 0.001). Operative mortality declined during the study period for both intact (4.9%-2.4%, P < 0.001) and ruptured (44.1%-36.3%, P < 0.001) AAA repair. Short-term AAA-related deaths decreased by more than half (26.1-12.1 per 100,000, P < 0.001), with the greatest decline occurring in those older than 80 years (53.7-27.3, P < 0.001).
E lective abdominal aortic aneurysm (AAA) repair is undertaken to prevent future rupture with its accompanying high mortality rate. 1, 2 Minimally invasive endovascular aneurysm repair (EVAR), Food and Drug Administration approved in 1999, has lower perioperative mortality and morbidity than open surgical repair in 3 randomized trials [3] [4] [5] and the US Medicare population. 6 Most elective AAA repairs in the United States are now performed using EVAR. 7, 8 The introduction of EVAR has changed the risks and benefits of elective aneurysm repair because it may now be offered to patients considered too high risk for traditional open repair. 7 Moreover, because of increased rates of advanced abdominal imaging, 9, 10 more AAAs are being detected incidentally than in the past. Thus, the introduction of EVAR combined with increased detection may be responsible for an increasing number of intact AAA repairs in the United States, which should ultimately result in lower mortality from AAA rupture.
There has been concern, however, that EVAR may not be as effective in preventing late rupture leading to potentially increased late mortality after repair. 11 In addition, the benefit of a prophylactic procedure in the most elderly patients is unproven because many of these patients will soon die from competing causes. Consequently, the population-level acute mortality impact of this increase in elective repairs after the introduction of EVAR is unknown. To understand the impact of these trends on a population level, we analyzed data on elective AAA repair and AAA rupture between 1995 and 2008 within the US Medicare population, which accounts for more than 70% of elective repairs and most deaths. We hypothesized that increased rates of detection and elective repair along with the introduction and increasing use of EVAR would be associated with decreased shortterm AAA-related mortality over time.
we included only those who had either EVAR (39.71) or open repair (38.44 or 39.25) during the same admission because the presence of a diagnostic code without an accompanying procedure might not indicate a clinically relevant AAA. Patients with AAA rupture were included only in the analysis if a diagnosis code for AAA rupture was their primary diagnosis because this is likely the reason for their index admission. Patients with diagnosis codes for AAA rupture in other diagnosis fields (fields other than the primary field) were excluded because these might be miscoded or indicate a history of AAA rupture not relevant to the index admission. Patients with AAA rupture were further divided into those undergoing repair (EVAR or open) or no repair. The ICD-9 code for endovascular repair was introduced in October 2000, so we used the code for stent placement (39.90) linked to a primary diagnosis of AAA for the preceding time period. To limit the study population to those with pure AAA, we excluded patients with concomitant codes for aortic dissection ( 
Outcomes
We define short-term mortality as the combined mortality related to elective repair, rupture repair, and death due to rupture without repair. Mortality related to elective repair was defined as death within 30 days of a repair procedure or within the repair hospitalization if more than 30 days. Mortality related to rupture was defined as all deaths within the primary hospitalization or within 30 days of a repair procedure for cases with a repair or within 30 days of admission for persons with a diagnosis of rupture who did not undergo repair. We note that many people with ruptured AAA die before arriving at a hospital, so these deaths are not counted in our analyses.
Analyses
We calculated the annual incidence and mortality rates of intact AAA repair, ruptured AAA repair, and rupture without repair per 100,000 Medicare beneficiaries. Standardized rates were calculated using the 2008 traditional Medicare enrollee data as our standard population. We first calculated standardized rates for males and females stratified by age group (65-74, 75-79, ≥80 years) for each year (1995) (1996) (1997) (1998) (1999) (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) . We then calculated standardized rates that were sex-and age-adjusted per year. Rates were analyzed overall and within subgroups stratified by age and sex. In descriptive analyses, we used linear regression models with 2-sided t tests to test whether the slope of the time trend was different from 0 and to detect significant changes in rates over time. We used the χ 2 test to compare mortality rates between EVAR and open repair for various populations. All statistical analyses were performed using SAS 9.1 (SAS Institute, Inc., Cary, NC). The study was approved by the institutional review board at Harvard Medical School.
RESULTS
A total of 338,278 patients underwent repair of intact AAA during the 14-year period. Total annual intact repairs increased slightly from 23,186 in 1995 to 24,334 in 2008. There were 69,653 patients with AAA ruptures presenting to a hospital, of which 47,524 were repaired, with the annual total number of ruptures decreasing from 6535 in 1995 to 3298 in 2008. All results reported are statistically significant at the P < 0.001 level unless otherwise stated.
Demographic and clinical characteristics of the US Medicare beneficiaries undergoing intact or ruptured AAA repair are shown in 3-year increments in Table 1 (data are available 
Rates of Repair of Intact and Ruptured AAAs
The overall rate of intact repair (age and sex adjusted) increased slightly (yet still significant statistically) from 79.9 to 85.0 per 100,000 Medicare beneficiaries during the period 1995 to 2008. Intact repair rates decreased in those 65 to 74 years old (range, 81.8-68.9), but increased in all other age groups, with the largest increase in those 80 years and older (57.7-92.3). Figure 1 shows changes in intact repair rates over time within these age groups relative to the baseline year (1995) . Although most intact repairs were in men, the increase in repairs was greater in women (10.2% increase in women vs 5.4% increase in men).
The rate of AAA ruptures presenting to a hospital (age and sex adjusted) decreased from 33.4 to 16.8 per 100,000 Medicare beneficiaries between 1995 and 2008, whereas the proportion of ruptures undergoing repair changed little during the same time period (70% in 1995 vs 65% in 2008).
The proportion of intact repairs using EVAR increased steadily over time, reaching 77% in 2008 for all age groups and 83% for those older than 80 years (see Figure, Supplemental Digital Content 2, available at: http://links.lww.com/SLA/A288, which shows proportion of EVAR for intact and ruptured AAA). Men were more likely to undergo EVAR than are women for all age groups in 2008 (79% vs 67%; data not shown). Although EVAR utilization for rupture repair has lagged behind that for intact repair, it grew to 31% in 2008.
Operative Mortality
Operative mortality with intact repair declined over time after the introduction of EVAR ( Fig. 2A ). Operative mortality with open repair remained fairly constant near 5%, so most of this decrease was due to the adoption of EVAR. The reduction in mortality with intact repair was greatest for those older than 80 years (9.6% in 1995 to 3.3% in 2008). Patients 65 to 74 years old had a smaller absolute reduction in mortality (3.3%-1.5%). Operative mortality was higher for women than for men for both endovascular repair (2.1% vs 1.3% in 2008) and open repair (7.0% vs 5.2% in 2008, P < 0.01), and this difference has changed little over time. Similarly, after the introduction of EVAR, the overall operative mortality with ruptured AAA repair declined from 44.1% in 1995 to 36.3% in 2008 ( Fig. 2B ).
Short-Term AAA-Related Deaths
Between 1995 and 2008, the overall rate of short-term AAArelated deaths for those presenting to a hospital (age and sex adjusted) per 100,000 Medicare beneficiaries declined from 26.1 to 12.1 (Fig.  3 ). This is due mostly to a 50% decline in the rate of ruptures and resulting deaths, which decreased from 20.2 to 9.1 per 100,000 beneficiaries. In addition, despite the increase in intact repairs, there was a decline in the rate of deaths related to intact repair from 5.9 to 3.0 per 100,000 beneficiaries (age and sex adjusted). The decline in all short-term AAA-related deaths was seen for both men and women and across all age groups, with the greatest decline seen in those 80 years and older (see Figure  4 shows that as the rate of intact AAA repair increased for those 80 years and older, there was a concomitant 50% decrease in rupturerelated deaths and a decrease in deaths due to intact AAA repair in that age group.
DISCUSSION
We studied trends in short-term AAA-related mortality during the period 1995 to 2008, which coincided with the period just before and after the introduction of EVAR and calculated standardized rates to correct for population changes. By using complete data from the Medicare program, we were able to capture all deaths within 30 days of presentation in a large population encompassing most AAA repairs and deaths in the United States. Our analysis has several key findings. First, rates of intact AAA repair increased dramatically in those older than 80 years and decreased somewhat in those younger than 75 years. Despite the increase in intact repair rates in those older than 80 years, operative mortality decreased by 50% because of the adoption of EVAR with its lower (and decreasing) mortality rates. Second, the incidence of AAA rupture has decreased dramatically over time, with 50% fewer deaths due to rupture observed in 2008 than in 1995. Because most ruptures occur in the oldest population, this finding is likely due to increasing rates of prophylactic elective repair in that population. Together, these trends have resulted in a marked decline in short-term AAA-related mortality over time, largely coinciding with the introduction and rise of EVAR.
In our previous work using the Nationwide Inpatient Sample, years 1993 to 2005, we previously demonstrated that the average annual number of deaths from intact and ruptured AAA decreased significantly after the introduction of EVAR. 7 However, the analysis did not account for changes in the population over time, was limited to in-hospital mortality, and was based on a 20% sample of hospitalizations. In contrast, the current study includes all Medicare beneficiaries and uniform data on short-term outcomes observed after discharge from the hospital. We now demonstrate substantial differences based on age and demonstrate changes occurring annually rather than 5-year averages.
Short-term AAA-related deaths in the United States are decreasing due to both fewer deaths after intact repair (despite an increase in repair rates primarily in those older than 80 years) and decreased incidence of rupture. Another contributing factor to decreased mortality from AAA rupture is that there might have been a change in the underlying prevalence of AAA. Previous epidemiologic studies based on data through 2000 have suggested an increasing or at least stable rate of AAA incidence, [12] [13] [14] [15] [16] [17] but these studies are now more than 10 years old. The population most likely to show decreased incidence of AAA are the youngest Medicare beneficiaries who might have benefited most from lower smoking rates and other risk factor control. 18 Our data also are consistent with this hypothesis. In younger patients (those 65-74 years old), we observed a decrease in the rate of rupture despite a decrease in the rate of intact repair. The decline in repair rate in this age group may also be related in part to the UK Small Aneurysm Trial and the subsequent Aneurysm Detection and Management trial, both of which demonstrated the safety of deferring AAA repair until the diameter reaches 5.5 cm. 19, 20 The fact that the rupture rate declined in this age group despite a decreasing rate of intact repair suggests that, for the first time, the incidence of AAA may be declining in younger patients. In contrast to younger patients, we observed markedly increased rates of intact repair for those 80 years and older along with a similar decrease in ruptures in that population. It is unlikely that we would have seen this dramatic increase if the prevalence of AAA was decreasing in this older population.
Before the introduction of EVAR, rates of AAA rupture and intact repair were generally stable, 1,14-17,21-23 although some more recent studies that include the early years after the introduction of EVAR showed a decreasing rate of intact repairs. 7, 8, 24, 25 For instance, Dillavou et al 24 found a decrease in intact repairs from 1994 to 2003 in a 5% sample of Medicare patients, whereas Nowygrod et al 25 found a stable rate of intact repair from 1998 to 2003 using state and national hospital discharge data. We find that the increase in intact repairs likely coincided with the introduction of EVAR. Close inspection reveals a spike in intact repairs in 2001 after Food and Drug Administration approval of EVAR, with a small decline in the years just before and after. It is likely that elective repair was deferred in those patients who were deemed most likely to benefit from EVAR in the years just before its introduction and that the small decline occurred after this backlog was eliminated. These overall trends, however, mask important differences by age group. Our analysis demonstrates that intact repair rates have been increasing dramatically in those older than 80 years since 1995, but that this increase is partially offset by a decrease in repair rates in those younger than 75 years.
Although EVAR has expanded access to repair, particularly for the oldest patients, we cannot confirm that life expectancy has been prolonged meaningfully because, although rupture may have been prevented, these patients may have died from other competing causes soon afterward. Thus, the benefit in reduction of short-term AAA-related mortality may not persist when examining the longterm benefits of EVAR. What is unambiguous, however, is that we observe fewer ruptures in this population. The recent EVAR 2 trial suggests that EVAR for unfit patients does not prolong survival. 26 We did not evaluate "fitness" and have simply noted trends based on age alone. We previously demonstrated that although operative mortality increases with age, a low mortality rate can be achieved even in Medicare patients 85 years and older (in-hospital mortality rate of only 2.7%). 6 Operative mortality rate in EVAR 2 was 9%, suggesting that these patients were substantially less "fit." In addition to age, comorbid conditions can be used to more precisely predict the operative risk with EVAR and open surgery for all age groups to help select those who may be at reasonable risk for EVAR even if they are high risk for open repair. 27, 28 We found a lower operative mortality rate with EVAR than with open repair for ruptured AAA similar to other studies. 24, 27, 29 It has been suggested that only the most stable patients with ruptures are chosen for EVAR and that mortality associated with EVAR and open repair of ruptured AAA may not be different. 30, 31 However, before the introduction of EVAR, rupture repair mortality had been stable. 23 Our analysis demonstrates a reduction in overall rupture repair mortality after the introduction of EVAR, providing the strongest argument in favor of a real reduction in operative mortality with EVAR for ruptures and intact AAA.
There are several limitations to this study. The administrative data we used are subject to coding errors and thus we might have missed some cases of repair. The trends we reported, however, would not be subject to such a bias unless coding accuracy was changing over time. Similarly, we were only able to identify rupture-related deaths that reached a hospital and most patients with AAA rupture likely die before reaching the hospital. However, we have no reason to suspect that the proportion of patients with AAA ruptures reaching the hospital would be changing over time; if anything we would expect that more ruptures would be reaching the hospitals because of improvements in the emergency response system. 32, 33 We also do not have the ability to determine why the proportion of patients admitted with ruptured AAA who are not offered repair has not changed substantially. We would hypothesize that some patients either present with the expressed desire not to undergo repair or present with an unrecoverable situation and that the expansion of EVAR would not impact this. Our analysis is also limited by a lack of anatomic information. We do not know AAA diameter and, therefore, cannot comment on changes in practice over time related to diameter. However, on the basis of the age-related trends we observed, we suspect that the increased utilization of EVAR represents an increase in the treatment of older adults (age 80 years and older) with larger diameter AAAs rather than expansion to treatment of smaller diameter AAAs.
In summary, coincident with the introduction of EVAR, we observed large population-level declines in short-term AAA-related mortality among elderly Medicare beneficiaries. This is due to both decreased perioperative mortality and decreased deaths due to ruptures of untreated (and treated) aneurysms, particularly in older patients. Expansion of the Medicare screening program and others could be expected to provide further benefits in reducing the AAA rupture rate nationally. Utilization of EVAR continues to expand for both intact and ruptured AAAs, suggesting that these trends will likely continue. Our data also suggest that AAA incidence might be decreasing in younger patients, potentially due to less smoking and improved risk factor control, but this finding will need to be confirmed in other studies. The authors have demonstrated a progressively increasing rate of repair of intact aneurysms over the period of study, which has led to a decrease in the rate of rupture, as measured by hospital admissions for rupture, and the rate of repairs for rupture.
DISCUSSANT
The overall rate of short-term aneurysm related death for those presenting to a hospital declined significantly over the period of study, due mostly to a reduction in the rate of rupture and resulting death. There also appears to be a reduction in the rupture repair mortality, possibly secondary to the use of endovascular repair. Clearly, the impact of these results is most evident in those patients over age 80.
The evidence points strongly to the increasing and preferential use of endovascular repair. The strength of these conclusions is supported by the capture of all data so analyzed from the Medicare program.
Unfortunately, the analysis includes only those patients with a procedural code for aneurysm repair or those patients with a primary diagnostic code for nonruptured or ruptured aneurysm. The analysis therefore may have missed many patients with intact aneurysms that were either not identified, not treated despite identification, or were not deemed large enough to warrant repair.
In addition, those patients with aneurysm rupture who died prior to hospital admission were not included in the analysis. Thus, an analysis of incidence or natural history may not be valid.
The methodology, however, was consistent during the period of study for hospitalized patients; therefore, an analysis of the trends remains valid.
In your presentation, you concluded that reduced rates of intact aneurysm repair and rupture in patients between ages 65 and 74 years may be attributed to a change in the natural history or a declining incidence of aneurysm. Did you evaluate the age specific incidence of comorbidities or medical risk over the period of study to see if we were, in fact, dealing with different patient populations?
Alternatively, is it possible that repair in recent years was deferred until a larger sac size was present, based on data from the UK, Small Aneurysm Trial, and other such studies, thus reducing the number and percentage of aneurysm repairs that would have been performed at an earlier period in the study?
Second, an endovascular rather than an open repair has been preferentially advocated in the elderly patient in many centers, especially those with greater medical risk. Was the benefit of this procedure unfairly distributed to those patients over age 80?
DR. MARC SCHERMERHORN: In answer to your first question, we did look at comorbidities over time. There have been increases in all the various comorbidities that you would typically associate with aortic aneurysm patients. Incidences of coronary artery disease, peripheral arterial disease, hypertension, congestive heart failure all increased.
We did not have access to data about rates of cigarette smoking or medication. Fortunately, others have done that for us. We know that the rates of cigarette smoking have decreased over time and the use of statins has increased. We think that perhaps there may be better control of hypertension.
We think that it is possible, for those reasons, that there may be a decreasing incidence of aortic aneurysm in the United States. There is some early evidence coming out of UK, Sweden, and Australia suggesting a declining incidence in those countries; so I think it is certainly possible.
In terms of are we deferring aneurysms? I would have to agree completely. I think the UK small aneurysm trial and the ADAM trial both have shown us it is safe to wait until aneurysms are up in the 5.5-centimeter range. I think a lot of that redistribution of those under 75 to those just over 75 may represent that.
That should decrease the overall rate of aneurysm repair that we do, as some patients will die of competitive causes during that observation period. Thus that should not be reflected in the increased rate of repair that we detected.
The other thing I think that contributes is the increased utilization of advanced abdominal imaging that has gone on over the last several decades. So we are probably identifying more aneurysms. We are then treating them selectively, waiting until they get bigger, and still repairing the correct ones that are larger at the initial discovery.
In terms of the other question, is the benefit unfairly distributed? I think, certainly, there is more benefit for the older patients. I think as you go up in risk, in perioperative risk, the benefit increases.
The delta in operative mortality is much larger if you are old or sick, where the EVAR is much less of a stress. I am not sure I would say it is unfair, but there is benefit to all patients. I think that, at this point in time, it may be that the only difference between those who get EVAR and open repair is anatomic as of 2012.
DR. KENNETH MATTOX (Houston, TX): Vascular trauma in the abdomen, particularly aortic injury from gunshot wound or stab wound, in the best of trauma centers in the world, still carries a 60% or greater mortality. Many trauma centers report 100% mortality from suprarenal aortic injury, even today.
Currently, general surgery trainees receive virtually no open or catheter-based training in vascular surgery. Vascular surgeons in training receive almost no trauma training. The military situation is even worse.
EVAR has had a significant impact on aortic rupture emergencies. That is very good. I would like to extrapolate now into the trauma.
Catheter-based intravascular proximal control, and even treatment, can and must be applied to the traumatic injury of the aorta, as it already has in the thoracic aorta, and now must be extended to the abdominal aorta.
The medial visceral rotation for abdominal aortic injury, which bears my name, needs to be replaced with EVAR technology. The medial rotation should be relegated to the curiosity section of the medical museum by using the acute care surgeon as the vascular surgery gatekeeper, and extending existing orthopedic C-arm technology, femoral sheath introducer, and even operating room permissive hypertension until the trained EVAR applicator becomes present.
My question to you, in policy perhaps cannot be answered today, but is a provocative question. What is the process for vascular surgery community to train the acute care surgeon into a true integrated network to create an integrated gatekeeper in complex vascular trauma to achieve the reduction in mortality in trauma that you have demonstrated with EVAR in the ruptured abdominal aortic aneurysm?
DR. MARC SCHERMERHORN I would not relegate your procedure to the curiosity wing; but I do agree that endovascular methods are the state of the art and that they should be more widely disseminated. I do not know what the appropriate training paradigm is. It is a matter of getting people in, doing more and more procedures with catheter and wires.
I think many people in the ACS community have started with placement of IVC filters, which is a fairly basic procedure. Some people are doing coil embolization of iliac bleeding vessels. I think partnering with radiologists and/or vascular surgeons would be the way to go for those cases during that training time. We have gone through a paradigm similar to that with cardiothoracic surgeons, to help getting them trained in placement of thoracic stent grafts.

DR. JAMES MAY (Sydney, NW):
We presented similar findings, comparing our experience in the 90s' decade to the 2000 decade, where, in the earlier period, the incidence of rupture that we were operating on was 15%. Whereas, in the 2000 decade, that incidence of rupture that we were operating on had fallen to 5%.
I think one of the unintended consequences of this is that, even though we are doing over 100 aneurysm repairs annually, only translate into five ruptures. Due to this decrease, our fellows, by the time they finish their year with us, still feel very uncomfortable with treating a ruptured aneurysm. I think that is something we need to give some thought to. DR. MARC SCHERMERHORN: I would agree completely. I think there are two things about that. As we decrease the incidence of rupture, there is subsequently less training for rupture, and then as we do more and more EVAR, nationally we are up to 31%. I believe at our hospital, we are probably in the 60 or 70% range of our ruptures that are treated with EVAR. We have fewer ruptures, and further a very few that are open. There are some that have to be treated with open surgery, it is going to become more difficult to get our trainees adequately trained to deal with those emergencies.
DISCUSSANT DR. K. CRAIG KENT (Madison, WI): I will begin by saying that I agree with your conclusions. However if I worked for CMS, I might pose a counterargument. CMS, of course, does not want to pay for all these extra endografts that are being placed. They might argue that there has been a great amount accomplished in risk factor modification over the last 15 years; e.g. fewer people are smoking, statins are being used. There are multiple other interventions that have been made that make people less likely to have progression of their aneurysmal disease. Could the increased use of EVAR be completely unrelated to the decrease in aneurysm rupture rate? Could we be experiencing fewer aneurysm ruptures because of better medical risk factor modification?
The second question relates to this 80-year-old group. The thesis is that if we put more endografts in patients that are greater than 80, they will not rupture their aneurysms and survival will be increased. The problem with 80-year-old is they die from many things. You can put an endograft in an 80-year-old, save them from their aneurysm and then have them die of lung cancer six months later. Have you shown any drop in all cause of mortality, not just aneurysm mortality, in this older age group with the use of endovascular repair?
DR. MARC SCHERMERHORN: Those are great points. In terms of the patients, particularly those over 80, can we prove that we are really prolonging survival? No. It is quite possible that every single one of those patients would have died a few weeks after their aneurysm was repaired. I think that is unlikely; but certainly, it is a possibility.
Though most patients would, I think, appreciate the fact that they can have their aneurysm repaired. It is going to be impossible for us to look at that in all-cause mortality in this patient population because of the relative infrequency of aortic aneurysms, even with 60,000 patients. With so many competitive causes for mortality, especially in that age group, it is going to be very difficult.
Regarding the hypothesis that this is all due to than the decrease in smoking and statins, and hypertension control; that is likely to make up a large part of the decrease in the younger population, I do not think it is the same for the older population. They have not had enough of the benefit of those changes. I think the big thing there, is that the rate of rupture was so steady for so many years. Then there is a very clear inflection point, when EVAR came along, and the rate of rupture dropped suddenly.
I think in terms of the 80-year-old, I think they simply represent a population of patients that were considered too old, too sick for open repair. Then they were just let to go, and ruptured in the past. Now that there is a minimally invasive option, we intervene and we prevent rupture.
